Ratnakar Securities Limited.

LINCOLN PHARMACEUTICALS LTD.

NSE : LINCOLNBSE : 531633ISIN CODE : INE405C01035Industry : Pharmaceuticals & DrugsHouse : Private

BSE617.00-6.35 (-1.02 %)

PREV CLOSE ( ) 623.35

OPEN PRICE ( ) 622.40

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1437

TODAY'S LOW / HIGH ( )615.65 623.35

52 WK LOW / HIGH ( )439.95 679.45

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 20-01 1995

Management Info

Kishor M Shah - Chairman Mahendra G Patel - Managing Director

Registered Office

Address Lincoln House", Behind Satyam Complex,Science City Road,Sola,
Ahmedabad,
Gujarat-380060

Phone 079-41078000

Email info@lincolnpharma.com

Website www.lincolnpharma.com

Registrars Details

MUFG Intime India Pvt Ltd.

506-508, 5th Floor, Amaranth Business Complex - I (ABC - I),Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura,Ahmedabad

Listing : BSE, NSE

NEWS

08Oct Lincoln Pharmaceuticals informs about
Lincoln Pharmaceuticals has informed that it enclosed Newspaper Advertis..

29Aug Lincoln Pharmaceuticals informs about
Lincoln Pharmaceuticals has informed that the 31st Annual General Meetin..

02Jul Lincoln Pharmaceuticals completes tria
Lincoln Pharmaceuticals has completed the trial run at its new manufactu..

02Jul Lincoln Pharmaceuticals informs about
Pursuant to Regulation 30 of the SEBI Listing Regulations, Lincoln Pharm..

15May Lincoln Pharmaceuticals informs about
Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosur..

Financials

in Millions

	QTR Dec 25	ANNUAL 25
Net Profit	286.01	823.469999999999
Gross Profit	347.23	1091.89
Operating Profit	387.42	1239.71
Net Sales	1663.22	6232.3

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Sanofi Cons. Health (BSE) 4411.85 (3.98%)	M.Cap ( in Cr)10160.76
Astrazeneca Pharma I (BSE) 8740.10 (1.67%)	M.Cap ( in Cr)21850.25
NGL Fine-Chem (BSE) 2404.35 (3.10%)	M.Cap ( in Cr)1485.41
Onesource Specialty (BSE) 1480.90 (4.13%)	M.Cap ( in Cr)16974.25
Neuland Laboratories (BSE) 13025.90 (0.43%)	M.Cap ( in Cr)16712.09

Shareholding Pattern

	PROMOTERS	49.78%
	NON-INSTITUTION	45.52%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Bandhan BSE Healthc...	0.03
Motilal Oswal BSE H...	0.03

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

LINCOLN PHARMACEUTICALS LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES